Eone Diagnomics Genome Center Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 64.9%.

Top 16 shareholders own 25.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.17%	Gyeong-Suk Lim	12,677,956	₩5.3b	24.9%	no data
7.97%	Korea Investment Private Equity	11,020,881	₩4.6b	0%	no data
3.99%	Min-Seop Lee	5,516,182	₩2.3b	82.4%	no data
2.4%	Diagnomics, Inc.	3,320,650	₩1.4b	0%	no data
1.09%	Eone Lifescience Institute Co., Ltd.	1,503,000	₩623.7m	0%	no data
0.34%	State Street Global Advisors, Inc.	464,067	₩192.6m	-3.05%	no data
0.058%	Seongha Lee	80,000	₩33.2m	0%	no data
0.019%	Chul-Ock Lee	26,344	₩10.9m	0%	no data
0.0062%	Jaehoon Jung	8,517	₩3.5m	0%	no data
0.0062%	Jae-hun Jeong	8,517	₩3.5m	0%	no data
0.0011%	Mirae Asset Global Investments Co., Ltd.	1,559	₩648.5k	-21.6%	no data
0.0011%	Samsung Asset Management Company, Ltd.	1,550	₩642.8k	-99.6%	no data
0.00064%	Yeongbo Kim	886	₩367.3k	0%	no data
0.00044%	Eone Diagnomics Genome Center Co.Ltd., Employee Stock Ownership Association	615	₩252.5k	0%	no data
0.00034%	Invesco Capital Management LLC	476	₩195.1k	0%	no data
0.00018%	Hanwha Asset Management Co. Ltd.	253	₩103.3k	0%	no data